1.
Basic & Clinical Medicine
;
(12): 722-726, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-693972
RESUMEN
Trastuzumab is a humanized monoclonal antibody that targets at human epidermal growth factor receptor 2(Her2)proto-oncogenes,which can act on Her2 over-expression of tumor cells,inhibits tumor cells proliferation, differentiation,migration and other physiological activities,reduces the risk of tumor metastasis and extend the sur-vival time of patients.